Fractyl Health, Inc. (GUTS) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 31 transactions totaling $22.2M, demonstrating a bullish sentiment with $21.8M in net insider flow. The most recent transaction on Jan 12, 2026 involved a transaction of 1,036,800 shares valued at $0.
No significant insider buying has been recorded for GUTS in the recent period.
No significant insider selling has been recorded for GUTS in the recent period.
Based on recent SEC filings, insider sentiment for GUTS is bullish with an Insider Alignment Score of 99/100 and a net flow of $21.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Fractyl Health, Inc. (GUTS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading GUTS stock, having executed 31 transactions in the past 90 days. The most active insider is Capital Management Lp M28 (Executive), who has made 2 transactions totaling $7.0M.
Get notified when executives and directors at GUTS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Lara Smith Weber | Chief Financial Officer | Award | 1,036,800 | $N/A | $0 | C-Suite |
| Dec 4, 2025 | Rajagopalan Harith | Executive | Purchase | 10,416 | $1.92 | $20.0K | |
| Sep 12, 2024 | David Caplan Jay | Executive | Sale | 65,000 | $2.90 | $188.5K | |
| Sep 12, 2024 | David Caplan Jay | Executive | Option Exercise | 95,484 | $1.70 | $162.3K | |
| Feb 6, 2024 | Llc Hcc Manager | Executive | Purchase | 333,333 | $15.00 | $5.0M | Large |
| Feb 6, 2024 | Llc Hcc Manager | Executive | Conversion | 920,661 | $N/A | $0 | |
| Feb 6, 2024 | Llc Hcc Manager | Executive | Conversion | 3,419,876 | $N/A | $0 | |
| Feb 6, 2024 | Design Fund Iii, L.p. Deerfield Private | Executive | Conversion | 76,706 | $N/A | $0 | |
| Feb 6, 2024 | Design Fund Iii, L.p. Deerfield Private | Executive | Conversion | 757,548 | $N/A | $0 | |
| Feb 6, 2024 | Management Lp M28 Capital | Executive | Purchase | 466,666 | $15.00 | $7.0M | Large |
| Feb 6, 2024 | Management Lp M28 Capital | Executive | Conversion | 1,389,451 | $N/A | $0 | |
| Feb 6, 2024 | Gp V, Llc General Catalyst | Executive | Conversion | 98,149 | $N/A | $0 | |
| Feb 6, 2024 | Gp V, Llc General Catalyst | Executive | Conversion | 4,702,161 | $N/A | $0 | |
| Feb 6, 2024 | Gp Lp Mithril II | Executive | Conversion | 5,160,301 | $N/A | $0 | |
| Feb 6, 2024 | Gp Lp Mithril II | Executive | Purchase | 333,333 | $15.00 | $5.0M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 5 | $22.0M | 98.4% |
Sale(S) | 1 | $188.5K | 0.8% |
Exercise(M) | 1 | $162.3K | 0.7% |
Award(A) | 1 | $0 | 0.0% |
Conversion(C) | 23 | $0 | 0.0% |
Insiders at Fractyl Health, Inc. are accumulating shares at an accelerated pace. With 14 insiders making 31 transactions totaling $22.0M in purchases versus $188.5K in sales, the net buying activity of $21.8M signals strong executive confidence. Capital Management Lp M28 (Executive) leads the buying activity with $7.0M in transactions across all time.